title: QTc prolongation and drugs.
authors.forename: W
authors.initials: W
authors.lastname: Henderson
authors.forename: J
authors.initials: J
authors.lastname: Chu
authors.forename: R
authors.initials: R
authors.lastname: Hoffman
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D001189:Aryl Hydrocarbon Hydroxylases; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D006634:Histamine H1 Antagonists / Q000009:adverse effects*; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D017336:Loratadine / Q000009:adverse effects*; D010089:Oxidoreductases, N-Demethylating / Q000378:metabolism; D010879:Piperazines; D014230:Triazoles / Q000009:adverse effects*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D006634:Histamine H1 Antagonists; D010879:Piperazines; D014230:Triazoles; C051752:nefazodone; D017336:Loratadine; D003577:Cytochrome P-450 Enzyme System; D001189:Aryl Hydrocarbon Hydroxylases; D051544:Cytochrome P-450 CYP3A; D010089:Oxidoreductases, N-Demethylating